iRemedy Secures Factory Capacity for Needles and Syringes Required for Administration of One+ Billion COVID-19 Vaccinations
STUART, FL – November 18, 2020 – The iRemedy Healthcare Companies, Inc. (“iRemedy” or “the Company”), pioneer of the iRemedy™ medical supply marketplace, today announced that in anticipation of COVID-19 vaccines becoming available soon, the Company has procured factory capacity for production of over one billion, FDA-approved hypodermic needles and syringes that will be required for administration of vaccinations to the public on a global basis.
2 months ago
iRemedy’s Project Restart Has Shipped 50 Care Boxes To In-Need Community Medical Centers Since Launching In Early August

4 months ago
iRemedy’s Project Restart Continues to Gain Momentum, Shipping Donated Medical Supplies to 15 More In-Need Clinics

5 months ago
iRemedy’s Project Restart Having Immediate Impact on Underserved, Underfunded Community Care Providers

6 months ago
iRemedy Launches Project Restart to Provide Underfunded Community Health Centers and Clinics with Free Medical Supplies

6 months ago
Putting PPE Front and Center
Brothers Tony and Gary Paquin started incubating iRemedy 15 years ago with the idea that retail products and services would be the next wave in healthcare. They founded Paquin Healthcare Companies to educate the U.S. healthcare industry on how to adapt and engage patients with retail models and technologies. In 2009, Tony’s book,“The Retail Healthcare Revolution”, laid out strategies for how healthcare institutions could get in on the consumer-driven market for products and services—and urged them to do so to remain profitable.
6 months ago
What makes iRemedy different?
Even in a time of crisis and product shortages, we know you’ve got options when it comes to medical supplies. When you place your trust in iRemedy, we absolutely guarantee customer satisfaction. It’s a promise we can deliver on because we don’t believe in doing business as usual. We’ve created an entirely new approach.
7 months ago
iRemedy and Verséa Holdings Team to Provide COVID-19 Rapid Test Serology Kits to U.S. Medical Providers
The iRemedy Healthcare Companies, Inc. (“iRemedy” or “the Company”), pioneer of the iRemedy ecommerce platform, and Verséa Holdings, a U.S.-based healthcare company focused on clinical research and novel scientific discoveries and products, today jointly announced the commercial availability of a COVID-19 Rapid Test Serology Kit that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for administration by U.S. healthcare providers in testing patients for coronavirus infection.
7 months ago
iRemedy to Lead Formation of The American Medical Manufacturing Coalition
Coalition’s Aim Will Be to Fully Align the Security, Economic, Social and Geopolitical Interests of Key Stakeholders in the U.S. Healthcare Supply Chain through the Manufacture and Distribution of Medical Devices/Equipment, Supplies and Drugs Made in America
7 months ago
iRemedy Provides Essential Protective Equipment to Arizona Healthcare Workers and First Responders at Peak Time
Innovative medical supply solution avoids supply chain shortfalls and begins delivery of millions of units of verified, critically-needed PPE as COVID-19 case count rises
8 months ago